...
机译:克服LCH中的T细胞耗尽:PD-1阻断和靶向MAPK抑制在LCH的小鼠模型中是协同的
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Tisch Canc Inst Dept Oncol Sci New York NY USA;
Childrens Natl Med Ctr Ctr Canc &
Immunol Res Washington DC 20010 USA;
Baylor Coll Med Dept Pathol Houston TX 77030 USA;
Tisch Canc Inst Dept Oncol Sci New York NY USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
Texas Childrens Hosp Texas Childrens Canc Ctr Houston TX 77030 USA;
机译:MA11.01 T细胞内在与外在PD-1阻断的对比疗效克服PD-L1 +肿瘤介导的耗尽
机译:由pH敏感的MSNP纳米载体递送的MAPK靶向药物与黑色素瘤中的PD-1阻滞协同作用而无T细胞抑制作用。
机译:用MAPK途径抑制治疗LCH儿童的临床应答和持久性BRAF V600E(+)血细胞
机译:白藜芦醇抑制菲尔伯酯诱导的小鼠皮肤中的环氧酶-2表达:MAPK和AP-1作为潜在的分子靶标
机译:通过抑制CAAX信号修饰和ERK MAPK途径,靶向Ras和Rho家族GTPases治疗癌症。
机译:MAPK通路的靶向抑制:进行性危及生命的多系统LCH的新兴救助选择
机译:针对地图途径的有针对性的抑制:逐步危及危及危及危及危及危及危及危及危及危及危及危及危及危及危及生命的多洋系统LCH的抑制作用
机译:在I型干扰素的抗体阻断后,寨卡病毒在高度易感的免疫活性小鼠模型中的神经病理发生。